A Year In Review
The RNA therapeutic landscape experienced transformative growth in 2024, driven by expanding applications in oncology, cardiovascular diseases, and immune-mediated disorders. With over 1,000 new drugs introduced and major advancements in siRNA, mRNA, and gene-editing modalities, RNA therapies are reshaping the future of precision medicine. Regulatory approvals and a wave of clinical trials showcase RNA’s potential beyond vaccines, further cementing its role in therapeutic innovation.
Download Now
Lead the future of ADC innovation!
Stay informed and stay competitive. The Beacon RNA 2024 Landscape Review is your comprehensive guide to RNA therapeutics, providing exclusive insights on clinical growth, emerging disease targets, and strategic investments.
Whether you’re scouting partnerships or aligning with regulatory trends, this report equips you with data-driven intelligence to confidently lead your next development strategy.
Report Contents
The Drug Landscape
Explore the latest growth trends across RNA modalities, with over 4,800 drugs spanning mRNA, siRNA, and beyond.
The Trial Landscape
Track RNA’s clinical momentum with 2,200+ ongoing trials and detailed insights into newly initiated programs.
The Commercial Landscape
Dive into strategic deal-making, with $70 billion in transactions reshaping RNA investments and partnerships.
The Future of RNA Therapeutics
Understand what’s next for RNA as targeting approaches redefine precision delivery.
Regulatory Announcements
Review pivotal 2024 approvals, IND submissions, and regulatory designations that are propelling RNA therapies forward.
Previous RNA Landscape Reviews
RNA 2024 H1 Landscape Review
An analysis of the RNA landscape in H1 of 2024
You May Also Be Interested In…
Drug Payload Quantification in LNPs with New Scatter-Free Absorption
Register Now
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
